Lv2
180 积分 2021-09-09 加入
Trimming Crystallizable Fragment (Fc) Glycans Enables the Direct Enzymatic Transfer of Biomacromolecules to Antibodies as Therapeutics**
19天前
已完结
Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms
22天前
已完结
Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling
23天前
已完结
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
23天前
已完结
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
23天前
已完结
Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms
23天前
已完结
First-in-class versus best-in-class: an update for new market dynamics
1个月前
已完结
MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells
2个月前
已完结
Synthetic lethality as an engine for cancer drug target discovery
2个月前
已完结
Abstract B177: The discovery and preclinical characterization of AMG 193, a first-in-class MTA-cooperative PRMT5 inhibitor with broad activity against MTAP-null cancers
2个月前
已关闭
皖公网安备34019202002308
